SummitTX Capital L.P. boosted its stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 441.2% in the first quarter, HoldingsChannel reports. The firm owned 28,689 shares of the company’s stock after purchasing an additional 23,388 shares during the quarter. SummitTX Capital L.P.’s holdings in Ryan Specialty were worth $968,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently modified their holdings of RYAN. Royal Bank of Canada boosted its holdings in shares of Ryan Specialty by 10.6% during the 1st quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock worth $4,406,000 after buying an additional 5,739 shares during the period. AQR Capital Management LLC increased its stake in shares of Ryan Specialty by 25.1% during the first quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock worth $367,000 after purchasing an additional 998 shares during the period. Goldman Sachs Group Inc. lifted its holdings in Ryan Specialty by 46.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock worth $27,787,000 after purchasing an additional 119,055 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Ryan Specialty by 11.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock valued at $24,586,000 after purchasing an additional 33,667 shares during the period. Finally, Creative Planning grew its holdings in Ryan Specialty by 15.4% in the 2nd quarter. Creative Planning now owns 4,586 shares of the company’s stock valued at $312,000 after buying an additional 613 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, Director John W. Rogers, Jr. purchased 7,500 shares of Ryan Specialty stock in a transaction that occurred on Wednesday, June 10th. The shares were acquired at an average price of $35.16 per share, for a total transaction of $263,700.00. Following the transaction, the director owned 117,933 shares of the company’s stock, valued at approximately $4,146,524.28. The trade was a 6.79% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Mark Stephen Katz acquired 3,215 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was purchased at an average cost of $31.07 per share, for a total transaction of $99,890.05. Following the completion of the purchase, the executive vice president directly owned 4,332 shares of the company’s stock, valued at $134,595.24. The trade was a 287.82% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders bought 130,715 shares of company stock worth $4,263,590. 52.03% of the stock is currently owned by corporate insiders.
Key Headlines Impacting Ryan Specialty
- Positive Sentiment: Ryan Specialty reported adjusted earnings of $0.74 per share, ahead of consensus estimates ranging from $0.60 to $0.61 and up from $0.66 a year earlier. Ryan Specialty Group Surpasses Q2 Earnings and Revenue Estimates
- Positive Sentiment: Second-quarter revenue increased 7.2% year over year to approximately $916.6 million, exceeding the roughly $874 million analyst estimate. The results indicate continued demand for the specialty insurance broker’s services. Ryan Specialty Reports Second Quarter 2026 Results
- Positive Sentiment: The earnings beat initially prompted a sharp positive market reaction, highlighting that profitability and revenue remained stronger than analysts had anticipated. Ryan Specialty Reports Strong Q2 CY2026
- Neutral Sentiment: Organic revenue growth was 6.7%, down from 7.1% in the prior-year quarter. That remains solid growth but suggests some moderation in underlying business momentum. Ryan Specialty Q2 Earnings Key Metrics
- Negative Sentiment: Net income declined 13.1% year over year, creating a notable contrast with the revenue and adjusted-EPS growth. Investors may be concerned that higher earnings were not accompanied by stronger bottom-line results. Ryan Specialty Second Quarter Results
- Negative Sentiment: The reaction also reflects elevated expectations and valuation sensitivity: a strong earnings beat may not be enough to sustain the stock if investors focus on slower organic growth and declining net income.
Ryan Specialty Stock Down 5.2%
Shares of NYSE RYAN opened at $44.06 on Friday. The stock has a market capitalization of $11.62 billion, a P/E ratio of 57.22, a PEG ratio of 1.01 and a beta of 0.61. The stock’s fifty day moving average is $37.51 and its 200 day moving average is $38.39. Ryan Specialty Holdings Inc. has a 52 week low of $29.28 and a 52 week high of $61.85. The company has a debt-to-equity ratio of 2.90, a quick ratio of 1.02 and a current ratio of 1.02.
Ryan Specialty (NYSE:RYAN – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.14. The business had revenue of $916.65 million during the quarter, compared to analysts’ expectations of $873.93 million. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.33%. Ryan Specialty’s revenue was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.66 earnings per share. Sell-side analysts forecast that Ryan Specialty Holdings Inc. will post 2.06 earnings per share for the current fiscal year.
Ryan Specialty declared that its Board of Directors has initiated a stock buyback plan on Tuesday, May 26th that allows the company to repurchase $300.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 3.5% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its stock is undervalued.
Wall Street Analyst Weigh In
Several research analysts have weighed in on RYAN shares. UBS Group lowered their price objective on Ryan Specialty from $52.00 to $50.00 and set a “buy” rating on the stock in a research report on Wednesday, July 8th. Wells Fargo & Company upped their price target on shares of Ryan Specialty from $31.00 to $39.00 and gave the company an “equal weight” rating in a research note on Thursday, July 9th. Wolfe Research lowered shares of Ryan Specialty from an “outperform” rating to a “peer perform” rating in a research report on Thursday, July 9th. Morgan Stanley lifted their price objective on shares of Ryan Specialty from $39.00 to $42.00 and gave the stock an “overweight” rating in a research note on Monday, July 6th. Finally, The Goldman Sachs Group boosted their price objective on shares of Ryan Specialty from $35.00 to $40.00 and gave the company a “neutral” rating in a report on Wednesday, July 1st. Eight analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $50.00.
Get Our Latest Stock Analysis on RYAN
Ryan Specialty Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Featured Articles
- Five stocks we like better than Ryan Specialty
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
